Journal of Pharmacy and Pharmacology · 1994 · 14 citations · 16 references
MedicineCardiologyPharmacologyBiochemical PharmacologyExperimental PharmacologyGeneral PharmacologyCardiac PharmacotherapyCardiovascular PharmacologyMast Cell PharmacologyNecrosisCardiovascular Drug PharmacologyCytokine Production By Mast CellsInfarct Size AssessmentInfarct Size QuantificationMechanisms Of Cardiac InjuryProtective Treatments
Policosanol is a mixture of higher aliphatic primary alcohols isolated from sugar cane (Saccharum officinarum L.) and octacosanol represents its main component. This study was conducted to examine the effects of policosanol on myocardial necrosis induced by subcutaneous injection of isoprenaline in rats. A significant reduction (P < 0.01) of infarct size, polymorphonuclear cells and mast cells was observed in animals treated with policosanol at 5 or 25 mg kg-1, while animals receiving only acetysalicylic acid pretreatment showed a significant decrease in the infarct area (P < 0.05). No significant differences in polymorphonuclear and mast cells were obtained when compared with positive control data. It is concluded that policosanol delays the evolution of infarction, showing a protective effect on the myocardial necrosis induced by isoprenaline in this experimental model.
16
Kevin Mullane, N G Read, J. Salmon et al. · Journal of Pharmacology and Experimental Therapeutics · 1984 · 471 citations
Veterinary Medicine, Cardiology, Cardiovascular Pharmacotherapy +14
Dermal mast cell degranulation in systemic sclerosis
James R. Seibold, Ralph Giorno, Henry N. Claman · Arthritis & Rheumatism · 1990 · 128 citations
Medicine, Dermatology, Immunology +16